Guggenheim Cuts Ultragenyx Price Target to $52 Amidst Analyst Rating Changes
Written by Emily J. Thompson, Senior Investment Analyst
Source: Benzinga
- Price Target Adjustment: Guggenheim cut Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) price target from $64 to $52 while maintaining a Buy rating, indicating a cautious outlook on the company's future growth potential.
- Transport Services Outlook: Baird raised the price target for J B Hunt Transport Services Inc (NASDAQ:JBHT) from $173 to $215, with analyst Daniel Moore maintaining an Outperform rating, reflecting optimism about a rebound in transportation demand.
- Electrical Equipment Upgrade: UBS increased Emerson Electric Co (NYSE:EMR) price target from $131 to $168 and upgraded the stock from Neutral to Buy, signaling enhanced market confidence in its future performance.
- Tech Stock Prospects: Jefferies raised IBM's (NYSE:IBM) price target from $300 to $360, with analyst Brent Thill upgrading the stock from Hold to Buy, acknowledging IBM's potential in cloud computing and AI sectors.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on EMR
Wall Street analysts forecast EMR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EMR is 150.46 USD with a low forecast of 125.00 USD and a high forecast of 170.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Analyst Rating
7 Buy
6 Hold
1 Sell
Moderate Buy
Current: 148.420
Low
125.00
Averages
150.46
High
170.00
Current: 148.420
Low
125.00
Averages
150.46
High
170.00
About EMR
Emerson Electric Co. is a global technology and software company that provides solutions for customers in a wide range of end markets around the world. The Company operates through seven segments under two business groups, such as Intelligent Devices and Software and Control. Its Intelligent Devices business includes Final Control, Measurement & Analytical, Discrete Automation, and Safety & Productivity. Software and Control business includes Control Systems & Software, Test & Measurement, and AspenTech. Its Final Control segment is a global provider of control valves, isolation valves, shutoff valves, pressure relief valves, pressure safety valves, actuators, and regulators for process and hybrid industries. Its Measurement & Analytical segment is a supplier of intelligent instrumentation measuring the physical properties of liquids or gases. AspenTech segment provides asset optimization software that enables industrial manufacturers to design, operate and maintain their operations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Oppenheimer Adjusts Ratings on Industrial Stocks
- Rating Adjustments: Oppenheimer reshuffled ratings across several large-cap industrial stocks, upgrading W.W. Grainger (GWW) and TE Connectivity (TEL) while downgrading Emerson Electric (EMR) and Ametek (AME) to neutral as their shares approached valuation targets.
- Downgrade of Emerson and Ametek: Emerson (EMR) and Ametek (AME) were downgraded from Outperform to Perform primarily due to strong share price appreciation bringing them close to Oppenheimer's price targets, reflecting investor confidence in Emerson's consistent organic growth over 20 consecutive quarters.
- Upgrade of Grainger and TE Connectivity: Oppenheimer upgraded W.W. Grainger (GWW) to Outperform with a 12- to 18-month price target of $1,250, expecting it to consistently outgrow the U.S. maintenance, repair, and operations market by 4% to 5% annually.
- Future Growth Outlook: Oppenheimer anticipates that Grainger and TE Connectivity will deliver faster organic growth than Emerson and Ametek over the next two years, supporting a more favorable risk-reward profile despite broader macro uncertainties in industrial end markets.
Continue Reading
Wall Street Analysts Adjust Ratings on Key Stocks
- Emerson Electric Downgrade: Oppenheimer analyst Christopher Glynn downgraded Emerson Electric Co (NYSE:EMR) from Outperform to Perform, reflecting market caution regarding its future growth, with shares closing at $149.13 on Monday.
- Skywater Technology Rating Change: Needham analyst N. Quinn Bolton downgraded Skywater Technology Inc (NASDAQ:SKYT) from Buy to Hold, indicating concerns about its short-term performance, as shares closed at $32.35 on Monday.
- Bitdeer Technologies Downgrade and Price Target Cut: Keefe, Bruyette & Woods analyst Stephen Glagola downgraded Bitdeer Technologies Group (NASDAQ:BTDR) from Outperform to Market Perform and cut the price target from $26.5 to $14, reflecting pessimism about its future profitability, with shares closing at $13.90 on Monday.
- Procter & Gamble Rating Adjustment: TD Cowen analyst Robert Moskow downgraded Procter & Gamble Co (NYSE:PG) from Buy to Hold, although raising the price target to $156, shares still closed at $149.49 on Monday, indicating market divergence regarding its growth potential.
Continue Reading